New Technologies for Endoscopic Treatment of Bleeding Gastroduodenal Ulcers
1 other identifier
interventional
112
1 country
1
Brief Summary
The purpose of the study was to improve treatment results of patients with bleeding gastroduodenal ulcers by endoscopic applications of autoplasma, enriched with platelets and granular sorbent aseptisorb-A.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 10, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 16, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2019
CompletedFirst Submitted
Initial submission to the registry
January 19, 2020
CompletedFirst Posted
Study publicly available on registry
January 23, 2020
CompletedJanuary 23, 2020
January 1, 2020
1.4 years
January 19, 2020
January 19, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the timing of final hemostasis
the timing of final hemostasis
a week
Secondary Outcomes (3)
the frequency of recurrent bleeding
1 year
mortality rates
1 year
healing of ulcerative defects
1 year
Study Arms (2)
Applications of autoplasma, enriched with platelets and
EXPERIMENTALEndoscopic applications of autoplasma, enriched with platelets and granular sorbent aseptisorb-A in bleeding gastroduodenal ulcers
Traditional methods of endoscopic hemostasis
OTHERTraditional methods of endoscopic hemostasis were used without the use of platelet-enriched plasma and granular sorbents.
Interventions
Complex endoscopic bleeding ulcers treatment with the use of granular sorbent aseptisorb-A and autoplasm enriched with platelets
Traditional methods of endoscopic hemostasis were used without the use of platelet-enriched plasma and granular sorbents
Eligibility Criteria
You may qualify if:
- Gastroduodenal ulcers with bleeding
You may not qualify if:
- Bleedings of other etiology
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Voronezh State Medical University
Voronezh, 394019, Russia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 19, 2020
First Posted
January 23, 2020
Study Start
January 10, 2018
Primary Completion
June 16, 2019
Study Completion
December 20, 2019
Last Updated
January 23, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share